Investigating the effectiveness of video narratives on medication understanding and use self-efficacy among stroke patients

Not Applicable

• Conditions: Stroke; Stroke - Ischaemic; Stroke - Haemorrhagic

• Registration Number: ACTRN12618000174280
• Lead Sponsor: School of Medicine and Health Sciences, Monash University, Malaysia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-05
• Last Update Posted: 12 November 2018

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

Inclusion criteria
1) Patient with definitive diagnosis of stroke (MRI/MRA,CT, CT angiography- confirmed diagnosis by neurologist).
2) Patient aged 18 years and above
3.Patient on antithrombotics and any stroke preventative medications (e.g. statins, hyperglycaemic agents, antihypertensive agents.
4) Patients who are able to converse, read and write in Malay or English.

Exclusion Criteria

Exclusion criteria
1) Patient with stroke due to accident, external or unexplained causes.
2) Patient with cognitive impairment and/or disorientation (MMSE score < 24)
3) Patient who depends help from caregivers to take their medications.
4) Patient with anxiety and/or depression (PHQ-9 score > 4)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome: changes in medication understanding and use self-efficacy measured using validated MUSE (medication understanding and use self-efficacy questionnaire). This is a composite primary outcome.<br>[Timepoint: Baseline, 1st, 3rd,6th and 12th month of study duration. <br>];Recurrent stroke events.<br>[Baseline, 1st,3rd,6th and 12th month of study duration.<br>]

Secondary Outcome Measures

Name	Time	Method
Secondary outcome 1: changes in medication adherence using validated (MARS) medication adherence rating scale<br><br><br>[ Baseline, 1st, 3rd,6th and 12th month of study duration<br>];Secondary outcome 2: changes in stroke knowledge using validated (SKT) stroke knowledge test[ Baseline, 1st, 3rd,6th and 12th month of study duration<br>];Secondary outcome 3: changes in belief about medicine using validated (BMQ) belief about medicine questionnaire[ Baseline, 1st, 3rd,6th and 12th month of study duration<br>];Secondary outcome 4: Stroke risk factor blood parameter control (blood pressure, fasting serum glucose, total cholestrol, INR), This is a composite secondary outcome.<br>[Baseline, 1st, 3rd,6th and 12th month of study duration]